Dr. Davies earned her medical degree from the University of Wales College of Medicine and completed her general medical training in Cardiff and Birmingham. She completed her Haematology Specialist training in Leeds and London. During this time, she also undertook research at the University of Leeds and the Dana-Farber Cancer Institute in Boston into the biology and treatment of multiple myeloma, concentrating on a number of potential new drugs and genetic technologies and their applications to myeloma.
In the United Kingdom, Dr. Davies’ focus has been on combining laboratory-based research on targeted approaches to myeloma therapy with clinical work involving the introduction of new drugs in the clinical setting. Emphasis has been on Phase I, II and II clinical trials. She is a member of the scientific advisory boards of both Myeloma UK and the International Myeloma Foundation.
Dr. Davies has received funding for her research from the Cancer Research UK, Kay Kendall Leukaemia Fund, Department of Health, Laeukemia Research Fund and British Society of Haematology. She has published over 100 papers in peer-reviewed journals, and has contributed to a number of book chapters and reviews on myeloma biology and treatment. She is also a reviewer for a number of international journals and grants.
Videos from the Patient Power Network
Professional Certifications and Education
UAMS doctors treat a broad range of conditions some of which may not be listed below.